Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The phase 2 trial for type 2 diabetes used similar starting doses to the obesity trial, with gradual titration
ZT: Data curation, Supervision, Validation, Writing review and editing
The majority of adverse events were mild, and although among our participants 6% discontinued treatment due to side effects, none experienced a serious adverse event
Calibration may therefore be biologically coherent, while the strength of the evidence remains dose-dependent
It slows gastric emptying meaning food moves through your stomach more slowly, keeping you fuller for longer
Tirzepatide is a synthetic incretin-class research peptide investigated in preclinical studies of metabolic signalling, glucose homeostasis and body-composition endpoints
US$ 20.77
US$ 28.01
US$ 21.16
US$ 26.84
US$ 24.74
US$ 20.38
US$ 29.28
